Indonesia approves first home-grown Covid vaccine for emergency use

Indonesia approves first home-grown Covid vaccine for emergency use

FILE PHOTO: A child receives the Sinovac Covid-19 vaccine at an elementary school in Jakarta on Dec 15, 2021, as part of a government programme to vaccinate children aged 6 to 11. Indonesia has approved its first domestically-produced Covid-19 vaccine for emergency use for people over 18, media said on Wednesday. (AFP)
FILE PHOTO: A child receives the Sinovac Covid-19 vaccine at an elementary school in Jakarta on Dec 15, 2021, as part of a government programme to vaccinate children aged 6 to 11. Indonesia has approved its first domestically-produced Covid-19 vaccine for emergency use for people over 18, media said on Wednesday. (AFP)

JAKARTA: Indonesia has approved its first domestically-produced Covid-19 vaccine for emergency use for people over 18, the chief of the country's food and drugs agency (BPOM) was quoted by news media as saying on Wednesday.

The Indovac vaccine has been developed by Indonesia's state-owned pharmaceutical company Bio Farma and the Baylor College of Medicine in Houston, Texas.

Penny Lukito, the head of BPOM, was cited by news portal CNN Indonesia as saying the approval was "given as a primary vaccine for adults".

Penny and a Bio Farma spokesperson did not immediately respond to requests for comment.

Bio Farma said this month it would produce 20 million doses of the vaccine in 2022 and 100 million doses by 2024. It has also said it has sought a halal certificate - which would make the vaccine permissible under Islam - from relevant authorities.

Indonesia is the world's biggest Muslim-majority nation.

Bio Farma chief Honesti Basyir said earlier this month that the vaccines were intended to "help reduce the nation's dependency on imported vaccines," adding 80% of Indovac is locally-sourced.

Indonesia, which reported one of the highest transmission rates of Covid-19 in the world last year, has used vaccines produced by China's Sinovac Biotech, Pfizer Inc and BioNTech as well as Moderna Inc.

Bio Farma has said it has also sought an emergency use approval from the World Health Organization (WHO).


Do you like the content of this article?
COMMENT (3)

BMA pleads with BTS to defer fare hike

The Bangkok Metropolitan Administration (BMA) is pleading with the Skytrain operator to put on hold a plan to raise fares by at least one baht from the first day of the New Year.

19:00

Crypto exchange Zipmex set for $100m buyout

The embattled cryptocurrency exchange Zipmex Asia is poised to be acquired by a venture capital fund for about US$100 million in digital coins and cash, one of the first rescues in Asia since a wave of defaults ripped through the sector.

17:38

Triad cash mystery

Police summons a former police officer and two women for questioning about the hidden assets of alleged Chinese triad leader “Tuhao", who is accused of involvement in the drug trade.

17:33